Beam Therapeutics (BEAM) is the lead sponsor of 6 active clinical trials listed on ClinicalTrials.gov[3], including 4 Phase 2[1], 5 Phase 1[2].
BEAM has 11 Form 4 insider filings recorded at the SEC in the past 30 days[4].
BEAM is tracked by BiotechSigns with a current catalyst score of 71/100 and grade B. The page summarizes 0 active signals, including 0 PDUFA, 0 insider buying, and 0 clinical trial signals, with data refreshed on 2026-06-03.
Beam Therapeutics (BEAM) is the lead sponsor of 6 active clinical trials listed on ClinicalTrials.gov[3], including 4 Phase 2[1], 5 Phase 1[2].
BEAM has 11 Form 4 insider filings recorded at the SEC in the past 30 days[4].